Is there a role for estrogens in the maintenance of men's health?

References

• Oettel M. Estrogens and antiestrogens in the male. In Oettel M, Schillinger E, eds. Handbook of Experimental Pharmacology, Vol. 135/II, Estrogens and Antiestrogens II. Berlin, Heidelberg: Springer- Verlag, 1999:505–71
   Google Scholar
• Oettel M, Hübler D, Winkelmann BR. Über das therapeutische Potential von Estrogenen beim Mann. J Menopause 2002;9:39–51
   Google Scholar
• Oettel M, Hübler D, Patchev V. Selected aspects of endocrine pharmacology of the aging male. Exp Gerontol 2003;38:189–98
   Google Scholar
• Levine AC, Kirschenbaum A, Gabrilove JL. The role of sex steroids in the pathogenesis and mainte- nance of benign prostatic hyperplasia. Mt Sinai J Med (NY) 1997;64:20–5
   Google Scholar
• Fishman J. Estrogens in the environment. Proceed- ings of the Symposium on Estrogens in the Environment, Raleigh, North Carolina, USA, September 10–12, 1979. Elsevier/North Holland 1980:73–9
   Google Scholar
• Janssen JAMJL, Stolk RP, Pols HAP, Grobbee DE, De Jong FH, Lamberts SWJ. Serum-free IGF-I, total IGF-I, IGFBP-1 and IGFBP-3 levels in an elderly population: relation to age and sex steroid levels. Clin Endocrinol 1998;48:471–8
   Google Scholar
• Baker HWG, Burger HG, de Kretser DM, et al. Changes in the pituitary-testicular system with age. Clin Endocrinol 1976;5:349–72
   Google Scholar
• Winkelmann BR, März W, Boehm BO, et al., on behalf of the LURIC study group. Rationale and design of the LURIC study – a resource for functional genomics, pharmacogenomics and long-term prognosis of cardiovascular disease. Pharmacogenomics 2001;2(Suppl 1):S1–73
   Google Scholar
• Leifke E, Gorenoi V, Wichers C, von zur Mühlen A, von Büren E, Brabant C. Age-related changes of serum sex hormones, insulin-like growth factor-1 and sex-hormone binding globulin levels in men; cross-sectional data from a healthy male cohort. Clin Endocrinol 2000;53:689–95
   Google Scholar
• Riggs BL, Khosla S, Melton LJ. Sex steroids and the construction and conservation of the adult skeleton. Endocr Rev 2002;23:279–302
   Google Scholar
• Oettel M, Hübler D, Patchev V, Winkelmann B. Physiology and therapeutic potential of estrogens in males. Gynecol Endocrinol 2001;15(Suppl 5):116
   Google Scholar
• Miller G. Endocrinology. Divorcing estrogen’s bright and dark sides. Science 2002;298:723–4
   Google Scholar
• Götz F, Patchev V. Personal communication to Jenapharm, October 2002
   Google Scholar
• Oettel M. Untersuchungen über die Verwendungsmöglichkeiten des Hundes bei der pharmakologisch-endokrinologischen und toxiko- logischen Prüfung von Sexualwirkstoffen. Disserta- tion zur Promotion B, Universität Leipzig, 1974
   Google Scholar
• Ogawa S, Lubahn DB, Korach KS, Pfaff DW. Behavioral effects of estrogen receptor gene dis- ruption in male mice. Proc Natl Acad Sci USA 1997;94:1476–81
   Google Scholar
• Bagatell CJ, Heiman JR, Rivier JE, Bremner WJ. Effects of endogenous testosterone and estradiol on sexual behavior in normal young men. J Clin Endocrinol Metab 1994;78:711–16
   Google Scholar
• Härkönen K, Huhtaniemi I, Koskenvuo M, et al. CAG repeat polymorphism in the androgen receptor gene and hormone levels, diseases and symptoms among aging men. Report to Jenapharm, 2002
   Google Scholar
• Bulun SE, Clinical review 78. Aromatase defi- ciency in women and men: would you have predicted the phenotypes? J Clin Endocrinol Metab 1996:1278–81
   Google Scholar
• Faustini-Fustini M, Rochira V, Carani C. Oestro- gen deficiency in men: where are we today? Eur J Endocrinol 1999;140:111–29
   Google Scholar
• Rochira V, Balestrieri A, Madeo B, Spaggiari A, Carani C. Congenital estrogen deficiency in men: a new syndrome with different phenotypes; clinical and therapeutic implications in men. Mol Cell Endocrinol 2002;193:19–28
   Google Scholar
• Carani C, Rochira V, Faustini-Fustini M, Balestrieri A, Granata ARM. Role of oestrogen in male sexual behaviour: insights from the natural model of aromatase deficiency. Clin Endocrinol 1999;51:517–24
   Google Scholar
• Smith EP, Boyd J, Frank GR, et al. Estrogen resistance caused by a mutation in the estrogen receptor gene in a man. N Engl J Med 1994;331:1056–61
   Google Scholar
• Center JR, Nguyen TV, Sambrook PN, Eisman JA. Hormonal and biochemical parameters in the determination of osteoporosis in elderly men. J Clin Endocrinol Metab 1999;84:3626–35
   Google Scholar
• Byers RJ, Hoyland JA, Braidman IP. Osteoporosis in men: a cellular endocrine perspective of an increasingly common clinical problem. J Endocrinol 2001;168:553–62
   Google Scholar
• Anderson FH, Francis RM, Hindmarsh P, Fall C, Cooper C. Serum oestradiol in osteoporotic and normal men is related to bone mineral density. In Papapoulos SE, Lips P, Pols HAP, Johnston CC, Delmas PD, eds. Osteoporosis 1996. Proceedings of the 1996 World Congress on Osteoporosis. Amsterdam: Elsevier, 1996:377–81
   Google Scholar
• Kaps P, Girg F. Die beherrschende Rolle des Östradiol (!) in der hypogonadalen Genese der Osteoporose – auch des Mannes. Osteologie 1998; 7(Suppl 1):91–2
   Google Scholar
• Gillberg P, Johansson AG, Ljunghall S. Decreased estradiol levels and free androgen index and elevated sex hormone-binding globulin levels in male idiopathic osteoporosis. Calcif Tissue Int 1999; 64:209–13
   Google Scholar
• Cordes U, Happ J. The importance of testosterone, estradiol and SHBG for the development of normal bone mass in eugonadal and hypogonadal men. Osteologie 1999;8:160–8
   Google Scholar
• Barrett-Connor EE, Mueller JE, von Mühlen DG, Laughlin GA, Schneider DL, Sartoris DJ. Low levels of estradiol are associated with vertebral fractures in older men, but not women: The Rancho Bernardo Study. J Clin Endocrinol Metab 2000;85:219–23
   Google Scholar
• Khosla S, Melton LJ, Atkinson EJ, O’Fallon WM. Relationship of serum sex steroid levels to longitudinal changes in bone density in young versus elderly men. J Clin Endocrinol Metab 2001; 86:3555–61
   Google Scholar
• Giagulli VA, Kaufman JA, Vermeulen A. Pathogenesis of decreased androgen levels in obese men. J Clin Endocrinol Metab 1994;79:997–1000
   Google Scholar
• Fischer S, Temelkova-Kürktschiev T, Köhler C, et al. Correlations between the sex hormones and various stages of glucose tolerance in men. Report to Jenapharm, 2001
   Google Scholar
• Abate N, Haffner SM, Abhimanyu G, Peshock RM, Grundy SM. Sex steroid hormones, upper body obesity, and insulin resistance. J Clin Endo- crinol Metab 2002;87:4522–7
   Google Scholar
• Gann PH, Henneckens CH, Longcope C, Verhoek-Oftedahl W, Grodstein F, Stampfer MJ. A prospective study of plasma hormone levels, nonhormonal factors, and development of benign prostatic hyperplasia. Prostate 1995;26:40–9
   Google Scholar
• Gray A, Feldman HA, McKinlay JB, Longcope C. Age, disease, and changing sex hormone levels in middle-aged men: Results of the Massachusetts Male Aging Study. J Clin Endocrinol Metab 1991; 73:1016–25
   Google Scholar
• Feldman HA, Longcope C, Derby CA, et al. Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study. J Clin Endocrinol Metab 2002;87:589–98
   Google Scholar
• Tikkanen MJ, Vihma V, Jauhiainen M, Höckerstedt A, Helisten H, Kaamanen M. Lipoprotein-associated estrogens. Cardiovascular Res 2002;56:184–8
   Google Scholar
• Virgili J, Casals I, Peinado-Onsurbe J, et al. Distri- bution of oleoyl-estrone in rat plasma lipoproteins. Horm Metab Res 1999;31:597–601
   Google Scholar
• Fernandéz-Real JM, Sanchis D, Ricart W, et al. Plasma oestrone-fatty acid ester levels are correlated with body fat mass in humans. Clin Endocrinol 1999;50:253–60
   Google Scholar
• Cullell-Young M, Del Fresno M. Oleoyl-estrone. Drugs of the Future 2002;27:648–54
   Google Scholar
• Stamler J, Pick R, Katz LN, et al. Effectiveness of estrogens for therapy of myocardial infarction in middle-aged men. J Am Med Assoc 1963;183:632–8
   Google Scholar
• Mügge A, Riedel M, Barton M, Kuhn M, Lichtlen PR. Endothelium independent relaxation of human coronary arteries by 17b-oestradiol in vitro. Cardiovasc Res 1993;27:1939–42
   Google Scholar
• New G, Duffy SJ, Harper RW, Meredith IT. Long-term oestrogen therapy is associated with improved endothelium-dependent vasodilation in the forearm resistance circulation of biological males. Clin Exp Pharmacol Physiol 2000;27:25–33
   Google Scholar
• Adamopoulos S, Leftheriotis D, Sbarouni E, Karavolias G, Kremastinos DT. Acute haemo- dynamic effects of oestrogen administration in male patients with chronic heart failure. Eur J Heart Failure 2002;4:719–26
   Google Scholar
• Del Rio G, Velardo A, Zizzo G, et al. Effect of estradiol on the sympathoadrenal response to mental stress in normal men. J Clin Endocrinol Metab 1994;79:836–40
   Google Scholar
• Komesaroff PA, Fullerton M, Esler MD, Jennings G, Sudhir K. Oestrogen supplementation attenuates responses to psychological stress in elderly men rendered hypogonadal after treatment for prostate cancer. Clin Endocrinol 2002;56:745–53
   Google Scholar
• Simpson E, Rubin G, Clyne C, et al. The role of local estrogen biosynthesis in males and females. TEM 2000;11:184–8
   Google Scholar
• McTernan PG, Anwar A, Eggo MC, Barnett AH, Stewart PM, Kumar S. Gender differences in the regulation of P450 aromatase expression and activity in human adipose tissue. Int J Obesity 2000; 24:875–81
   Google Scholar
• Faustini-Fustini M, Rochira V, Carani C. Oestro- gen deficiency in men: where are we today? Eur J Endocrinol 1999;15:1261–70
   Google Scholar
• Liu DM, Dillon JS. Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to G_(i2,3). J Biol Chem 2002;277:21379–88
   Google Scholar
• Arlt W, Haas J, Callies F, et al. Biotransformation of oral dehydroepiandrosterone in elderly men: significant increase in circulating estrogens. J Clin Endocrinol Metab 1999;84:2170–6
   Google Scholar
• Arlt W, Callies F, Koehler I, et al. Dehydro- epiandrosterone supplementation in healthy men with an age-related decline of dehydroepiandro- sterone secretion. J Clin Endocrinol Metab 2001; 86:4686–92
   Google Scholar
• Elger W, Kaufmann G, Sobek L. Personal communications to Jenapharm, 1997
   Google Scholar
• Finkelstein M, Weidenfeld J, Ne’Eman Y. Comparative studies of the aromatization of testosterone and epitestosterone by human placental aromatase. Endocrinology 1981;108:943–7
   Google Scholar
• Sheean LA, Meigs RA. Inhibitor specificity of the placental microsomal oxidase system responsible for the aromatization of epitestosterone (17b- hydroxy-4-androsten-3-one). Steroids 1983;41:225–41
   Google Scholar
• Hobe G, Schön R, Goncharov N, et al. Some aspects of 17a-estradiol metabolism in man. Steroids 2002;67:883–93
   Google Scholar
• Buko VU, Lukivskaya O, Naruta F, et al. Anti- atherogenic effects of 17b-estradiol and 17a- estradiol and its derivative J 811 in cholesterol-fed rabbits with thyroid inhibition. Climacteric 2001; 4:49–57
   Google Scholar
• Uebelhart B, Bonjour JP, Draper MW, et al. Effects of the selective estrogen receptor modulator raloxifene (RXL) on bone metabolism in healthy males. ASBMR 22nd Annual Meeting. J Bone Miner Res 2000;15:S229
   Google Scholar
• Anderson JJB, Garner SC. The effects of phyto- estrogens on bone. Nutr Res 1997;17:1617–32
   Google Scholar
• Teede HJ, Dalais FS, Kotsopoulos D, Liang YL, Davis S, McGrath BP. Dietary soy has both beneficial and potentially adverse cardiovascular effects: a placebo-controlled study in men and postmenopausal women. J Clin Endocrinol Metab 2001;86:3053–60
   Google Scholar
• Debruyne F, Koch G, Boyle P, et al. Comparison of a phytotherapeutic agent (Permixon) with an alpha-blocker (Tamsulosin) in the treatment of benign prostatic hyperplasia: a 1-year randomized international study. Eur Urol 2002;41:497–506
   Google Scholar
• Jellinck PH, Michnovicz JJ, Bradlow HL. Influence of indole-3-carbinol on the hepatic microsomal formation of catechol estrogens. Steroids 1991;56:446–50
   Google Scholar
• Michnovicz JJ. Increased estrogen 2-hydroxylation in obese women using oral indole-3-carbinol. Int J Obesity 1998;22:227–9
   Google Scholar
• Hörhold-Schubert C, Hobe G, Kaufmann G, Schumann G. Zur Biotransformation von Dienogest durch Mikroorganismen. In Teichmann AT, ed. Dienogest – Präklinik und Klinik eines Gestagens, 2nd edn. Berlin: Walter de Gruyter, 1995:51–8
   Google Scholar
• Witorsch RJ. Endocrine disruption: a critical review of environmental estrogens from a mecha- nistic perspective. Toxic Substance Mechanisms 2000; 19:53–78
   Google Scholar
• Bolt HM, Janning P, Michna H, Degen GH. Comparative assessment of endocrine modulators with oestrogenic activity. I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against background of European developments. Arch Toxicol 2001;74:649–62
   Google Scholar
• Bolt HM, Degen GH. Comparative assessment of endocrine modulators with oestrogenic activity. II. Persistent organochlorine pollutants. Arch Toxicol 2002;76:187–93
   Google Scholar
• Degen GH, Janning P, Wittsiepe J, Upmeier A, Bolt HM. Integration of mechanistic data in the toxicological evaluation of endocrine modulators. Toxicol Lett 2002;127:225–37
   Google Scholar
• Witorsch RJ. Low-dose in utero effects of xeno- estrogens in mice and their relevance to humans: an analytical review of the literature. Food Chem Toxicol 2002;40:905–12
   Google Scholar
• Sharpe RM, Skakkebaek NE. Are estrogens involved in falling sperm counts and disorders of the male reproductive tract? Lancet 1993;341:1392–5
   Google Scholar
• Nieschlag E, Lerchl A. Declining sperm counts in European men – fact or fiction? Andrologia 1996;28:305–6
   Google Scholar
• Quinn MM, Wegman DH, Greaves IA, et al. Investigation of reports of sexual dysfunction among male chemical workers manufacturing stilbene derivatives. Am J Ind Med 1990;18:55–68
   Google Scholar
• Oliva A, Giami A, Multigner L. Environmental agents and erectile dysfunction: a study in a con- sulting population. J Androl 2002;23:546–50
   Google Scholar